These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20647630)

  • 21. Effect of carvedilol therapy on functional mitral regurgitation, ventricular remodeling, and contractility in patients with heart failure due to left ventricular systolic dysfunction.
    Comin-Colet J; Sánchez-Corral MA; Manito N; Gómez-Hospital JA; Roca J; Fernández-Nofrerias E; Valdovinos P; Esplugas E
    Transplant Proc; 2002 Feb; 34(1):177-8. PubMed ID: 11959238
    [No Abstract]   [Full Text] [Related]  

  • 22. Beta blockers for congestive heart failure.
    Gilbert EM
    Postgrad Med; 1998 Feb; 103(2):25-6. PubMed ID: 9479305
    [No Abstract]   [Full Text] [Related]  

  • 23. Left ventricular systolic dysfunction in a cardiac transplant recipient treated with carvedilol.
    Gardner RS; McGowan J; McDonagh TA
    Eur J Heart Fail; 2002 Jun; 4(3):377-9. PubMed ID: 12034165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carvedilol: use in chronic heart failure.
    Doughty RN; White HD
    Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):21-31. PubMed ID: 17187454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of carvedilol on right ventricular function in chronic heart failure.
    Quaife RA; Christian PE; Gilbert EM; Datz FL; Volkman K; Bristow MR
    Am J Cardiol; 1998 Jan; 81(2):247-50. PubMed ID: 9591916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of pretreatment systolic blood pressure on benefit from carvedilol in severe chronic heart failure patients.
    Ghali JK
    J Am Coll Cardiol; 2005 Mar; 45(5):809; author reply 809-10. PubMed ID: 15734634
    [No Abstract]   [Full Text] [Related]  

  • 27. Safety and efficacy of carvedilol in very elderly diabetic patients with heart failure.
    Del Sindaco D; Pulignano G; Cioffi G; Tarantini L; Di Lenarda A; De Feo S; Opasich C; Minardi G; Giovannini E; Leggio F
    J Cardiovasc Med (Hagerstown); 2007 Sep; 8(9):675-82. PubMed ID: 17700396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta-blockers in heart failure. The 'new wave' of clinical trials.
    Krum H
    Drugs; 1999 Aug; 58(2):203-10. PubMed ID: 10473016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carvedilol in the treatment of chronic heart failure: lessons from the Carvedilol Or Metoprolol European Trial.
    Kveiborg B; Major-Petersen A; Christiansen B; Torp-Pedersen C
    Vasc Health Risk Manag; 2007; 3(1):31-7. PubMed ID: 17583173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carvedilol therapy in heart failure--III.
    Lee YC
    J Am Coll Cardiol; 1995 Nov; 26(5):1400-1. PubMed ID: 7594061
    [No Abstract]   [Full Text] [Related]  

  • 31. The large-scale placebo-controlled beta-blocker studies in systolic heart failure revisited: results from CIBIS-II, COPERNICUS and SENIORS-SHF compared with stratified subsets from MERIT-HF.
    Wikstrand J; Wedel H; Castagno D; McMurray JJ
    J Intern Med; 2014 Feb; 275(2):134-43. PubMed ID: 24118421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The COMET study compares effect of two different beta-blockers in chronic heart failure. Carvedilol better than metoprolol].
    Swedberg K
    Lakartidningen; 2003 Sep; 100(37):2852-4. PubMed ID: 14558169
    [No Abstract]   [Full Text] [Related]  

  • 33. [Therapy with beta blockers in heart failure. Recent studies of carvedilol].
    Böhm M; Erdmann E
    Fortschr Med; 1996 May; 114(13):167-8. PubMed ID: 8964561
    [No Abstract]   [Full Text] [Related]  

  • 34. Unique effects of carvedilol on noradrenaline release in the human heart.
    Richardt G; Richardt D; Adler S; Kraatz E; Nötzold A; Kurz T
    Eur J Heart Fail; 2002 Mar; 4(2):147-9. PubMed ID: 11959042
    [No Abstract]   [Full Text] [Related]  

  • 35. Carvedilol for the treatment of benign prostatic hypertrophy in patients with heart failure?
    Rohrer CK; Page RL; Shakar SF; Lindenfeld J
    J Card Fail; 2011 Oct; 17(10):875-7. PubMed ID: 21962427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Commentary on the Carvedilol or Metoprolol European Trial (COMET).
    Poole-Wilson PA
    Am J Cardiol; 2004 May; 93(9A):40B-2B. PubMed ID: 15144936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Re: Effect of carvedilol on plasma adiponectin concentration in patients with chronic heart failure.
    Lou YF; Shi XP; Tong H; Yu GY; Yao GD; Dong K
    Circ J; 2009 Dec; 73(12):2363; author reply 2364. PubMed ID: 19940373
    [No Abstract]   [Full Text] [Related]  

  • 38. Carvedilol for heart failure, with care.
    Cleland JG; Swedberg K
    Lancet; 1996 May; 347(9010):1199-201. PubMed ID: 8622445
    [No Abstract]   [Full Text] [Related]  

  • 39. Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10-Year Cohort.
    Tang CH; Wang CC; Chen TH; Hong CY; Sue YM
    J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26738790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
    Fonarow GC; Abraham WT; Albert NM; Stough WG; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy C; Young JB;
    Am Heart J; 2007 Jan; 153(1):82.e1-11. PubMed ID: 17174643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.